Web Symposium Highlight
Presentation VideoVideo ChaptersDownloadable PDFFully ResponsiveAsk us for a PREVIEW
Marketing
Reach your clientele, get your message across. Evidence-based stories that compel your audience.
Conferences
Let us contribute to your symposium by input on the program and solutions to highlight its contents.
Medical Writer
A professional healthcare writer improves the reporting of trial results and benefits both quality and readability.
Medical Blogs
Our healthcare writer can summarise highly technical content for broader audiences, clearly communicating the key points.
Presentations
Stunning slide decks can profoundly improve impact, whether for marketing purposes, medical meetings or advisory boards.
Graphic Design
Beautiful artwork and illustrations can lift the impact of the written word. Pay tribute to your publication with stunning graphic design.
Medical Writer Support
How can we help your project?
Interested in MediPaper's tailored and professional medical writer solutions? Our unique business model allows for sharp pricing! See how our medical writer agency can help your project and request a price estimation.
We appreciate your interest in working with MediPaper Medical Communications.
Our Experience
© Copyright - MediPaper Medical Communications - Medical Writer 醫學作家
Member of
HealthNews
- Dramatic Improvement in NHL Outcomes With CAR T-Cell Versus Standard Therap... September 20, 2017Treatment with the autologous anti-CD19 CAR T-cell therapy axicabtagene ciloleucel significantly improved outcomes in refractory non-Hodgkin lymphoma compared with standard therapies.
- Cabozantinib, Nivolumab Active in Metastatic Urothelial Carcinoma September 20, 2017Cabozantinib and nivolumab with or without ipilimumab show activity in genitourinary tumors, particularly urothelial carcinoma, and have manageable safety profiles.
- Facebook trial lets users hide alcohol adverts September 20, 2017The social network is testing a tool that will let people hide categories of ads for the first time.
- CAR T-Cell Therapy Active in High-Risk, Refractory CLL September 20, 2017Patients with refractory chronic lymphocytic leukemia achieved a high-response rate with CD19-targeted CAR T-cell therapy JCAR014.
- Fracture Risk Higher for Seniors With Diabetes September 20, 2017Bone weaknesses seen in those with blood sugar disease